secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0000950170-23-068439
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema furnishes investor presentation at SABCS; no specific data disclosed
--------------------------------------------------------------------------

- Investor presentation dated December 6, 2023 made available on company website.
- Presentation exhibited as Exhibit 99.1 but full content not included in filing text.
- No financial results, clinical data updates, or guidance changes referenced in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017023068439/0000950170-23-068439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017023068439/olma-20231206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-068439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer